ICOS, an important member of the CD28/CTLA-4 family found on TFH cells, is being targeted with the monoclonal antibody MEDI-570 in an ongoing phase I trial in patients with PTCL follicular variant and AITL (NCT02520791). The gene discussed is ICOS; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.